Cerebain Biotech Releases Initial Photos of Its First Prototype of the Company's Medical Device Product for Treatment of Alzheimer's
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos”), has provided photos of the first prototype of the Company’s medical device solution for the treatment of Alzheimer’s disease utilizing the Omentum.
Help employers find you! Check out all the jobs and post your resume.
DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos”), has provided photos of the first prototype of the Company’s medical device solution for the treatment of Alzheimer’s disease utilizing the Omentum.
Help employers find you! Check out all the jobs and post your resume.